全文获取类型
收费全文 | 2328篇 |
免费 | 103篇 |
国内免费 | 9篇 |
专业分类
耳鼻咽喉 | 9篇 |
儿科学 | 44篇 |
妇产科学 | 18篇 |
基础医学 | 274篇 |
口腔科学 | 50篇 |
临床医学 | 121篇 |
内科学 | 553篇 |
皮肤病学 | 52篇 |
神经病学 | 269篇 |
特种医学 | 74篇 |
外科学 | 358篇 |
综合类 | 8篇 |
预防医学 | 84篇 |
眼科学 | 20篇 |
药学 | 142篇 |
中国医学 | 3篇 |
肿瘤学 | 361篇 |
出版年
2024年 | 3篇 |
2023年 | 19篇 |
2022年 | 33篇 |
2021年 | 58篇 |
2020年 | 26篇 |
2019年 | 41篇 |
2018年 | 50篇 |
2017年 | 42篇 |
2016年 | 54篇 |
2015年 | 72篇 |
2014年 | 74篇 |
2013年 | 81篇 |
2012年 | 149篇 |
2011年 | 162篇 |
2010年 | 93篇 |
2009年 | 93篇 |
2008年 | 134篇 |
2007年 | 159篇 |
2006年 | 132篇 |
2005年 | 140篇 |
2004年 | 116篇 |
2003年 | 107篇 |
2002年 | 135篇 |
2001年 | 33篇 |
2000年 | 25篇 |
1999年 | 34篇 |
1998年 | 31篇 |
1997年 | 19篇 |
1996年 | 35篇 |
1995年 | 29篇 |
1994年 | 19篇 |
1993年 | 24篇 |
1992年 | 32篇 |
1991年 | 30篇 |
1990年 | 18篇 |
1989年 | 13篇 |
1988年 | 18篇 |
1987年 | 16篇 |
1986年 | 16篇 |
1985年 | 11篇 |
1984年 | 9篇 |
1983年 | 11篇 |
1982年 | 4篇 |
1981年 | 7篇 |
1980年 | 4篇 |
1979年 | 7篇 |
1978年 | 6篇 |
1972年 | 3篇 |
1968年 | 2篇 |
1967年 | 4篇 |
排序方式: 共有2440条查询结果,搜索用时 15 毫秒
101.
In order to examine the promoting effect of urinary crystals on urinary bladder carcinogenesis, acetazolamide, uracil, and diethylene glycol, all of which have been reported to cause urinary crystals or calculi, were administered to male F344 rats for 32 weeks after pretreatment with 0.05% N-butyl-N-(4-hydroxybutyl)nitrosamine (BBN) for 4 weeks. A marked increase in urinary crystals was observed in acetazolamide-treated rats and a slight increase in crystals was observed in uracil- and diethylene glycol-treated rats. Histological examination of the urinary bladder revealed that the BBN-acetazolamide treatment resulted in a higher incidence of carcinoma than BBN-control. Uracil and diethylene glycol did not cause any significant difference compared to the control. Promoting effects by urinary crystals were not clearly shown in the present experiment and, therefore, urinary crystals appear to play a very limited role, if any, in urinary bladder carcinogenesis. 相似文献
102.
103.
Nishida N Yamashita S Mimori K Sudo T Tanaka F Shibata K Yamamoto H Ishii H Doki Y Mori M 《Annals of surgical oncology》2012,19(9):3065-3071
Purpose
Recent evidence has shown that altered patterns of microRNA (miRNA) expression correlate with various human cancers. We investigated the clinical significance of miR-10b and its involvement in chemotherapeutic resistance to 5-fluorouracil (5-FU), which is a key component of common chemotherapy regimens in colorectal cancer.Methods
Quantitative RT-PCR was used to evaluate the clinicopathologic significance of miR-10b expression in 88 colorectal cancer cases. We also investigated the chemotherapeutic sensitivity to 5-FU in miR-10b-overexpressing colorectal cancer cells. To explore the mechanism of chemoresistance in miR-10b transfected cells, we examined whether miR-10b inhibits the pro-apoptotic BH3-only Bcl-2 family member BIM(BCL2L11), a key mediator of chemotherapy-induced cell death.Results
High level miR-10b expression was found to be significantly associated with high incidence of lymphatic invasion (P?=?0.0257) and poor prognosis (P?=?0.0057). Multivariate analysis indicated that high miR-10b expression is an independent prognostic factor for survival. In vitro studies revealed that miR-10b directly inhibits pro-apoptotic BIM, and the overexpression of miR-10b confers chemoresistance in colorectal cancer cells to 5-FU.Conclusions
MiR-10b is a novel prognostic marker in colorectal cancer. Moreover, the expression of miR-10b is a potential indicator of chemosensitivity to the common 5-FU-based chemotherapy regimen. 相似文献104.
105.
Tsuchida Y Takahashi A Suzuki N Kuroiwa M Murai H Toki F Kawarasaki H Hashizume K Honna T 《Journal of pediatric surgery》2002,37(2):165-167
Background: The incidence of intrahepatic cholelithiasis and cholangitis has not yet been well studied postoperatively in patients with choledochal cysts. Methods: One hundred three patients with choledochal cysts had operative cholangiography, underwent standard excision of a choledochal cyst with Roux-en-Y hepatico-jejunal anastomosis, and were at a mean follow-up of 12[frac12] years. The incidence of intrahepatic bile duct stones was analyzed according to the 3 morphologic types of intrahepatic bile duct observed at initial operative cholangiography: type 1, no dilatation of the intrahepatic bile ducts; type 2, dilatation of the intrahepatic bile ducts but without any downstream stenosis; and type 3, dilatation of the intrahepatic bile ducts associated with downstream stenosis. Initially, there was no evidence of intrahepatic bile duct stones in any of the 103 patients. Results: Among 50 type 1 patients, intrahepatic cholelithiasis developed in only 1 patient (2%). Among 43 type 2 patients, 1 patient (2%) had intrahepatic cholelithiasis, and 2 (5%) had postoperative cholangitis. Among 10 type 3 patients, 4 (40%) had intrahepatic cholelithiasis (P [lt ] .01), and 3 (30%) had postoperative cholangitis. Time intervals between the initial surgery and the first identification of intrahepatic stones ranged from 3 to 22 years. Conclusions: One of the major causes of formation of intrahepatic cholelithiasis has been clarified; patients with intrahepatic biliary dilatation with downstream stenosis can get intrahepatic bile duct stones long after excision of a choledochal cyst. 相似文献
106.
Toshihiko Nouchi Yujiro Tanaka Toyohiro Tsukada Chifumi Sato Fumiaki Marumo 《Liver international》1991,11(2):100-105
ABSTRACT— The appearance of α-smooth-muscle-actin (α-smA)-positive cells during hepatic fibrosis was studied immunohistochemically in rat and human livers. In the normal rat liver, α-smA was observed only in vascular smooth muscle cells. With the progression of fibrosis induced by CCl4 injection, α-smA-positive cells appeared in the perisinusoidal space and the fibrous septa, and ultimately surrounded regenerative nodules. An increase of desmin-positive cells was recognized in the fibrotic areas and the perisinusoidal area. In the human liver, α-smA-positive cells appeared in the fibrotic area, whereas no desmin-positive cells were observed, except in vascular walls of the central vein and the portal tract. α-smA is a good marker for the detection of myofibroblast-like cells, and the appearance of α-smA in liver mesenchymal cells seems closely related to the process of hepatic fibrosis in both rat and man. 相似文献
107.
108.
Yukio Kobayashi Kensei Tobinai Akihiro Takeshita Kensuke Naito Osamu Asai Nobuaki Dobashi Shinpei Furusawa Kenji Saito Kinuko Mitani Yasuo Morishima Michinori Ogura Fumiaki Yoshiba Tomomitsu Hotta Masami Bessho Shin Matsuda Jin Takeuchi Shuichi Miyawaki Tomoki Naoe Noriko Usui Ryuzo Ohno 《International journal of hematology》2009,89(4):460-469
The primary objective of this study was to investigate the tolerability, efficacy and pharmacokinetic profile of gemtuzumab
ozogamicin (GO) in patients with relapsed and/or refractory CD33-positive acute myeloid leukemia (AML). Patients received
2-h infusions of GO twice with an interval of approximately 14 days. Tolerability was assessed using the National Cancer Institute
Common Toxicity Criteria Version 2.0. Samples for pharmacokinetics were taken on day 1 and day 8 of the first treatment cycle.
The dose was increased stepwise and, in each cohort, patients were treated at the same dose. Forty patients, median age 58 years
(range 28–68) were treated; 20 and 20 patients were enrolled to the phase I and II parts, respectively. In the phase I part,
dose-limiting toxicities (DLTs) were hepatotoxicities, and the recommended dose was established as 9 mg/m2 given as two intravenous infusions separated by approximately 14 days. The pharmacokinetic study revealed that C
max and AUC were equivalent to those of non-Japanese patients. In the phase II part, complete remission was observed in 5 patients,
and one patient had complete remission without platelet recovery. Four of these 6 in remission and one in the phase I are
long-term survivors (alive for at least 44 months). GO is safe and effective as a single agent among Japanese CD33-positive
AML patients. Remission lasted longer in a subset of patients than in non-Japanese patients in earlier studies. Further studies
of this agent are warranted to establish standard therapy.
S. Furusawa: deceased. 相似文献
109.
Shirao S Kashiwagi S Sato M Miwa S Nakao F Kurokawa T Todoroki-Ikeda N Mogami K Mizukami Y Kuriyama S Haze K Suzuki M Kobayashi S 《Circulation research》2002,91(2):112-119
Although recent investigations have suggested that a Rho-kinase-mediated Ca2+ sensitization of vascular smooth muscle contraction plays a critical role in the pathogenesis of cerebral and coronary vasospasm, the upstream of this signal transduction has not been elucidated. In addition, the involvement of protein kinase C (PKC) may also be related to cerebral vasospasm. We recently reported that sphingosylphosphorylcholine (SPC), a sphingolipid, induces Rho-kinase-mediated Ca2+ sensitization in pig coronary arteries. The purpose of this present study was to examine the possible mediation of SPC in Ca2+ sensitization of the bovine middle cerebral artery (MCA) and the relation to signal transduction pathways mediated by Rho-kinase and PKC. In intact MCA, SPC induced a concentration-dependent (EC50=3.0 micromol/L) contraction, without [Ca2+]i elevation. In membrane-permeabilized MCA, SPC induced Ca2+ sensitization even in the absence of added GTP, which is required for activation of G-proteins coupled to membrane receptors. The SPC-induced Ca2+ sensitization was blocked by a Rho-kinase inhibitor (Y-27632) and a dominant-negative Rho-kinase, but not by a pseudosubstrate peptide for conventional PKC, which abolished the Ca2+-independent contraction induced by phorbol ester. In contrast, phorbol ester-induced Ca2+ sensitization was resistant to a Rho-kinase inhibitor and a dominant-negative Rho-kinase. In primary cultured vascular smooth muscle cells, SPC induced the translocation of cytosolic Rho-kinase to the cell membrane. We propose that SPC is a novel messenger for Rho-kinase-mediated Ca2+ sensitization of cerebral arterial smooth muscle and, therefore, may play a pivotal role in the pathogenesis of abnormal contraction of the cerebral artery such as vasospasm. The SPC/Rho-kinase pathway functions independently of the PKC pathway. 相似文献
110.
Fumiaki Ono Takumi Okihara Noboru Osaka Noriyuki Nagaoka Yuji Kameoka Akira Ishikawa Hironari Ooki Takumi Ito Daisuke Todome Shinya Uemoto Mitsuaki Furutani Tsutomu Inokuchi Kenji Okada 《RSC advances》2022,12(6):3300
Nitrogen/phosphorus-containing melamines (NPCM), a durable flame-retardant, were prepared by the successive treatment of ArOH (Ar = BrnC6H5−n, n = 0, 1, 2, and 3) with POCl3 and melamine monomer. The prepared flame-retardants were grafted through the CH2 unit to lignocellulose nanofibers (LCNFs) by the Mannich reaction. The resulting three-component products were characterized using FT-IR (ATR) and EA. The thermal behavior of the NPCM-treated LCNF fabric samples was determined using TGA and DSC analyses, and their flammability resistances were evaluated by measuring their Limited Oxygen Index (LOI) and the UL-94V test. A multitude of flame retardant elements in the fabric samples increased the LOI values as much as 45 from 20 of the untreated LCNFs. Moreover, the morphology of both the NPCM-treated LCNFs and their burnt fabrics was studied with a scanning electron microscope (SEM). The heat release lowering effect of the LCNF fabric against the water-based paint was observed with a cone calorimeter. Furthermore, the mechanical properties represented as the tensile strength of the NPCM-treated LCNF fabrics revealed that the increase of the NPCM content in the PP-composites led to an increased bending strength with enhancing the flame-retardance.LCNFs were grafted with nitrogen/phosphorus-containing melamines to achieve potent flame-retardance and converted to PP-composites of improved mechanical properties. 相似文献